Strides Pharma

Update in progress

STAR.NS (NSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products globally, including generic tablets, capsules, sachets, liquids, nasal sprays, gels, powders, ointments, and creams. It offers branded generics for chronic therapies in women’s health, CNS, cardiovascular, diabetes, dermatology, and probiotics under Renerve, Unibrol, Combiart, Duotab, and Vitafer, plus institutional lines for HIV, malaria, TB, Hepatitis, and other infections. Formerly Strides Shasun, renamed in 2018. Founded 1990, Bengaluru, India.

Company score

Sentiment: 0.05; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.02; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.15; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.02; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.04; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.01; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive